$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Etrasimod tablets (Etrasimod)-Velsipity domestic drug purchase channels, usage and dosage, and patient usage guide analysis
2026-02-01 22:25:32
Check Details
Analysis of indications, treatment scope, clinical efficacy and usage guidelines of Rutrombopag (Wenda)
2026-02-01 22:25:32
Check Details
Detailed analysis of how to take Omarigliptin and when to take it
2026-02-01 22:25:32
Check Details
Lecanemab-LEQEMBI long-term use recommendations and analysis of discontinuation risks and safety
2026-02-01 22:25:32
Check Details
Analysis of pharmacological properties and clinical treatment principles of golodirsen
2026-02-01 22:25:32
Check Details
Disitamab’s launch time, approval progress and analysis of domestic and foreign drug purchase channels
2026-02-01 22:25:32
Check Details
Analysis of whether isatuximab (Xacoyi) is a targeted drug and its mechanism of action and clinical application principles
2026-02-01 22:25:32
Check Details
Evaluation of the efficacy of capicitinib in tumor treatment and the experience of different patients
2026-02-01 22:25:32
Check Details
Differences in indications and efficacy and comparison of clinical applications between guselkumab (Tenoya) and cosentyx
2026-02-01 22:25:32
Check Details
Tenapanor hydrochloride (tenapanor) latest price reference in 2026 and analysis of drug purchase channels and cost explanations
2026-02-01 22:25:32
Check Details
Analysis of revumenib-REVUFORJ market pricing, reference price range and formal drug purchase channels
2026-02-01 22:25:32
Check Details
The efficacy of inavolisib combined with palbociclib and fulvestrant
2026-02-01 22:25:32
Check Details
1
2
...
2388
2389
2390
2391
2392
2393
2394
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
2
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
3
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
4
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
5
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
9
Adagrasib Medication Management Guide for Special Populations
10
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
11
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
12
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment